Patents Assigned to SANDA CORPORATION
  • CRLF-2 BINDING PEPTIDES, PROTOCELLS AND VIRAL-LIKE PARTICLES USEFUL IN THE TREATMENT OF CANCER, INCLUDING ACUTE LYMPHOBLASTIC LEUKEMIA (ALL)
    Publication number: 20150010475
    Abstract: The present invention relates to the use of which are attached or anchored phospholipid biolayers further modified by CRLF-2 and CD 19 binding peptides which may be used for delivering pharmaceutical cargos, to cells expressing CRLF-2 and CD 19, thereby treating cancer, in particular, acute lymphoblastic leukemia (ALL), including (B-precursor acute lymphoblastic leukemia (B-ALL). Novel CRLF-2 binding peptides and CLRF-2 and CD19-binding viral-like particles (VLPs) useful in the treatment of cancer, including ALL are also provided.
    Type: Application
    Filed: December 31, 2012
    Publication date: January 8, 2015
    Applicants: SANDA CORPORATION
    Inventors: C. Jeffrey Brinker, David S. Peabody, Walker Kip Wharton, Bryce Chackerian, Carlee Erin Ashley, Cheryl L. Willman, Eric C. Carnes, Katherine Epler, Robert Eric Castillo